메뉴 건너뛰기




Volumn 83, Issue 13, 2011, Pages 5028-5036

Analytical strategies for assessment of human metabolites in preclinical safety testing

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL STRATEGY; DATA-MINING TOOLS; DRUG METABOLITES; HUMAN METABOLITES; IN-VIVO;

EID: 79960013720     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac200349g     Document Type: Article
Times cited : (67)

References (39)
  • 1
    • 79960009445 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. Guidance for Industry: Safety Testing of Drug Metabolites.
    • U.S. Food and Drug Administration. Guidance for Industry: Safety Testing of Drug Metabolites. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm079266.pdf. 2008.
    • (2008)
  • 2
    • 79959984911 scopus 로고    scopus 로고
    • International Conference on Harmonisation. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2).
    • International Conference on Harmonisation. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). http://private.ich.org/LOB/media/MEDIA5544.pdf. 2009.
    • (2009)
  • 11
    • 84889367186 scopus 로고    scopus 로고
    • In; Zhang, D.; Zhu, M.; Humphreys, W. G., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, pp.
    • Ma, S.; Chowdhury, S. K. In Drug Metabolism in Drug Design and Development; Zhang, D.; Zhu, M.; Humphreys, W. G., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2008, pp 319-367.
    • (2008) Drug Metabolism in Drug Design and Development , pp. 319-367
    • Ma, S.1    Chowdhury, S.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.